Panax notoginseng and performance

What 2 graded rows on panax notoginseng agree on for performance, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Panax notoginseng page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Panax notoginseng page, with its PubMed record.

Supplement

Panax notoginseng Choose another

2 rows · 119 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade C, is a meta-analysis of 90 people (2022) and found an improvement.

The rows run from 29 to 90 people, published from 2005 to 2022: 1 pooled review and 1 single study.

2 improved

Grade CExercise endurance (Panax genus) · Improved
Meta-analysis · n 90 · 2022 · Healthy adults in 5 trials
Varied · Varied
Time to exhaustion improved (SMD 0.58); the review was funded by a ginseng-extract maker and found possible publication bias.
Row on the Panax notoginseng page · PubMed 35334841 (opens PubMed)
Grade DEndurance time to exhaustion · Improved
RCT · n 29 · 2005 · Untrained adults aged 20–35
1,350 mg/day · 30 days
Endurance cycling time rose by more than 7 minutes, and peak blood pressure and oxygen use at 24 minutes fell, compared with placebo.
Row on the Panax notoginseng page · PubMed 15744902 (opens PubMed)